GlaxoSmithKline lung drug Anoro approved in Europe

GSK Survey Points to Rise of COPD in US

In the last decade, COPD has risen from the fourth leading cause of death in the US to the third, and COPD prevalence has also increased from from six to seven percent of adults ages 40 years and older.